HeartBeam Inc. BEAT Archives - Page 7 of 8

FridayNov 11, 2022 11:38 am

QualityStocksNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q3 2022 Financial Report

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for heart attack detection anytime, anywhere, is reporting its financial and operational updates for the third quarter; the quarter ended on Sept. 30, 2022. Included in the report is the fact that the company’s AIMI(TM) platform technology, which is used for diagnosing heart attacks, has been submitted to the U.S Food and Drug Administration (“FDA”) for clearance and the company is on track for initial FDA submission of its AIMIGo(TM) device in the next quarter. Other highlights include that the company broadened…

TuesdayOct 25, 2022 12:05 pm

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q3 2022 Results Conference Call

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, today announced that it will hold a conference call at 4:30 p.m ET on Thursday, Nov. 10, 2022. HeartBeam CEO and Founder Branislav Vajdic, PhD, CFO Richard Brounstein, and CBO Jon Hunt, PhD, will host the call, during which time they will discuss the company’s results for the third quarter ended Sept. 30, 2022, and review recent announcements, ongoing initiatives, and key 2022 and anticipated 2023 milestones, followed by a question-and-answer period. A presentation will accompany the…

FridayOct 21, 2022 3:05 pm

QualityStocksNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Patented Breakthrough Technology Poised to Disrupt ECG Patch Market

HeartBeam (NASDAQ: BEAT) recently received a patent from the United States Patent and Trademark Office for its 12-lead electrocardiogram (“ECG”) patch monitor for the detection of acute coronary syndrome (“ACS”) and cardiac arrhythmia. “The new patent expands on a previously granted patent for a 12-lead ECG patch monitor technology. HeartBeam noted that the patent opens a pathway to a disruptive ischemia and arrhythmia detection ECG patch product. In addition, the innovation builds on HeartBeam’s growing intellectual property portfolio that could enable 12-lead ECG diagnostics outside of a medical setting… Currently, the ECG patch monitor market is limited to detecting arrhythmias…

MondayOct 17, 2022 2:34 pm

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Featured in BioWorld(TM) MedTech Article

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed an innovative platform for heart attack detection anytime, anywhere, was featured in a recent BioWorld(TM) MedTech article. “HeartBeam Inc. has been awarded a patent for what it called ‘the first and only’ 3D-vector, 12-lead ECG platform for heart attack detection, this in conjunction with a credit card-sized device inside a consumer’s wallet for personal monitoring,” the piece reads. “The company said it can record and remotely transmit a set of cardiac signals to a physician for review so that patients at high risk of cardiac arrest are not left alone…

ThursdayOct 13, 2022 11:33 am

QualityStocksNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Participate at Upcoming LD Micro Main Event XV Conference

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, is slated to present at this month’s LD Micro Main Event XV Conference. Scheduled for Oct. 25–27, 2022, the three-day event will be held in Los Angeles. HeartBeam CEO and founder Branislav Vajdic, PhD, will present live during the conference. His presentation will begin at 7:30 p.m. ET on Oct. 25 and can be viewed in person or online. A replay of the presentation will also be available following the event on the HeartBeam investor relations website.…

TuesdayOct 11, 2022 1:19 pm

QualityStocksNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Appoints Seasoned Veteran as New Chief Medical Officer

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, has named a new chief medical officer. Renowned Stanford cardiologist Peter J. Fitzgerald, MD, PhD, will be joining the HeartBeam executive team and will support the planned advancement of the company’s product pipeline. Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory at Stanford University Medical School, Fitzgerald is an interventional cardiologist and has led or participated in more than 175 clinical trials and has published some 650 manuscripts/chapters. He has…

MondayOct 10, 2022 1:35 pm

QualityStocksNewsBreaks – Why HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’

HeartBeam (NASDAQ: BEAT) is a cardiac technology company whose initial focus is on providing diagnostic data through its 3D-vector 12-lead electrocardiogram (“ECG”) platform – the first and only to be developed – for heart attack detection anytime, anywhere. Its development portfolio includes HeartBeam AIMI(TM), a software that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately and speedily identify a heart attack in acute care settings. Also under development is HeartBeam AIMIGo(TM), the first and only credit card-sized 12-lead output ECG device for remote heart attack detection that combines a smartphone app and cloud-based diagnostic software…

ThursdayOct 06, 2022 12:40 pm

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Platform to Add 24/7 Heart Monitoring Capability

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, today announced the expansion of its product portfolio pipeline to serve the growing cardiac device wearable technology market by bringing clinically relevant diagnostic information to patients and clinicians. According to the update, the product pipeline advancement allows for the addition of arrhythmia detection capabilities to address the multibillion global market for atrial fibrillation and other arrhythmia monitoring. “Adding smartwatch connectivity to our platform is a significant development as it extends our portfolio by enabling 24/7 heart monitoring…

MondayOct 03, 2022 10:45 am

HeartBeam Inc. (NASDAQ: BEAT) Receives US Patent for Exclusive ECG Patch Monitor Designed to Detect Heart Issues

The USPTO issued a patent for BEAT’s 12-lead electrocardiogram (“ECG”) patch monitor for detection of ACS and cardiac arrhythmia HeartBeam has developed the only 3D-vector ECG platform for heart-attack detection anytime, anywhere BEAT’s patch technology could have a disruptive effect on the ECG patch market with its ischemia detection capability News about heart attacks and other life-threatening cardiovascular issues is alarming. Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States (https://ibn.fm/FN4BR), and recent reports suggest that COVID-19 may cause heart problems (https://ibn.fm/7QAky) and that the incidence of heart…

ThursdaySep 29, 2022 1:57 pm

QualityStocksNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Announces Participation in Two Investor Events

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, will be attending and presenting at two upcoming investor conference: the Dawson James Small Cap Growth Conference and The ThinkEquity Conference. Slated for Oct. 12, 2022, the Dawson James event will be held in Jupiter, Florida. HeartBeam founder and CEO Branislav Vajdic, PhD, will be joined by chief financial officer Rick Brounstein and chief business officer Jon Hunt, PhD, at the conference to deliver the company’s presentation and also meet one-on-one with meeting attendees. The presentation is…

Site Search

Company Search

Tag: HeartBeam Inc. BEAT